Suryansh Kidney Care Profile
Key Indicators
- Authorised Capital ₹ 0.30 M
- Paid Up Capital ₹ 0.10 M
- Company Age 15 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 32.49%
- Profit Growth 85.10%
- Ebitda -50.77%
- Net Worth -2.52%
- Total Assets 2.08%
About Suryansh Kidney Care
Suryansh Kidney Care Private Limited (SKCPL) is a Private Limited Indian Non-Government Company incorporated in India on 30 November 2009 and has a history of 15 years and two months. Its registered office is in Lucknow, Uttar Pradesh, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.30 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Deepak Dewan and Udita Dewan serve as directors at the Company.
Company Details
-
Location
Lucknow, Uttar Pradesh, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U85191UP2009PTC038804
-
Company No.
038804
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
30 Nov 2009
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Suryansh Kidney Care?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Udita Dewan
|
Director | 30-Nov-2009 | Current |
|
Deepak Dewan
|
Director | 30-Nov-2009 | Current |
Financial Performance of Suryansh Kidney Care.
Suryansh Kidney Care Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 32.49% increase. The company also saw a substantial improvement in profitability, with a 85.1% increase in profit. The company's net worth dipped by a decrease of 2.52%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Suryansh Kidney Care?
In 2020, Suryansh Kidney Care had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Niharika Kidney Care Private LimitedDeepak Dewan and Udita Dewan are mutual person
-
Dewan Life Sciences Private Limited
Deepak Dewan and Udita Dewan are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Suryansh Kidney Care?
Unlock and access historical data on people associated with Suryansh Kidney Care, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Suryansh Kidney Care, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Suryansh Kidney Care's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
